Voglibose can prevent diabetes

Scientists believe a drug used to lower glucose levels in diabetics can delay or even prevent the disease in at-risk individuals. Voglibose, an alpha-glucosidase inhibitor, is used to lower postprandial blood glucose levels in diabetics. According to a study published in The Lancet, voglibose lowers the risk of developing diabetes in individuals predisposed to the condition by 40 percent. The drug reduces the amount of glucose absorbed into the bloodstream, helping 54 percent of the patients to achieve normal blood sugar levels. Scientists concluded that lifestyle modification along with long-term prophylaxis with this drug in individuals with impaired glucose tolerance can lower the incidence of type 2 diabetes.